Literature DB >> 8238252

Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

J H Jansen1, K Høgåsen, T E Mollnes.   

Abstract

Massive glomerular deposits of C3 and the terminal C5b-9 complement complex (TCC), but no immune complex deposits were detected by immunofluorescence in porcine membranoproliferative glomerulonephritis type II. TCC deposits were always observed with concomitant deposits of vitronectin (S-protein) in membranoproliferative glomerulonephritis, in contrast to a piglet with mesangial glomerulopathy where TCC was present without vitronectin co-deposition. Enzyme immunoassays revealed extensive systemic complement activation in 1-week-old affected piglets, observed by low plasma C3 (about 5% of normal) and high plasma TCC (about 10 x normal). Affected piglets revealed some plasma complement activation already at birth, 3 to 4 weeks before recognizable clinical disease. It is concluded that porcine membranoproliferative glomerulonephritis represents a nonimmune complex-mediated glomerulonephritis caused by unrestricted systemic complement activation with C3 consumption, TCC formation, and glomerular trapping of complement activation products. A pathogenetic mechanism of a defective or missing complement regulation protein is suggested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238252      PMCID: PMC1887163     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Correlation between the human and porcine complement system: a small-angle scattering study of cross immunity and methylamine-induced conformational changes of porcine C3 and C4 proteins.

Authors:  R Osterberg; B Malmensten; T Boive; U Nilsson; T Stigbrand; K Mortensen
Journal:  Mol Immunol       Date:  1991-09       Impact factor: 4.407

2.  Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.

Authors:  K N Lai; S T Lo; F M Lai
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

3.  Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.

Authors:  M Schulze; J V Donadio; C J Pruchno; P J Baker; R J Johnson; R A Stahl; S Watkins; D C Martin; R Wurzner; O Gotze
Journal:  Kidney Int       Date:  1991-09       Impact factor: 10.612

4.  Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex.

Authors:  K Høgåsen; T E Mollnes; M Harboe
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

Review 5.  Mesangiocapillary glomerulonephritis.

Authors:  G D'Amico; F Ferrario
Journal:  J Am Soc Nephrol       Date:  1992-04       Impact factor: 10.121

6.  Urinary excretion of terminal complement complexes in glomerular disease.

Authors:  Y Kusunoki; Y Akutsu; N Itami; H Tochimaru; Y Nagata; Y Takekoshi; A Sagawa; Y Kataoka; S Nagasawa
Journal:  Nephron       Date:  1991       Impact factor: 2.847

7.  Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.

Authors:  C J Pruchno; M M Burns; M Schulze; R J Johnson; P J Baker; C E Alpers; W G Couser
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement.

Authors:  L C Cork; J M Morris; J L Olson; S Krakowka; A J Swift; J A Winkelstein
Journal:  Clin Immunol Immunopathol       Date:  1991-09

9.  Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).

Authors:  T E Mollnes; H Redl; K Høgåsen; A Bengtsson; P Garred; L Speilberg; T Lea; M Oppermann; O Götze; G Schlag
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

10.  Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.

Authors:  C J Pruchno; M W Burns; M Schulze; R J Johnson; P J Baker; W G Couser
Journal:  Kidney Int       Date:  1989-07       Impact factor: 10.612

View more
  20 in total

1.  The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

Authors:  Guido A Hegasy; Tamara Manuelian; Kolbjorn Hogasen; Johan H Jansen; Peter F Zipfel
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

3.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Authors:  Peter Popp Wibroe; Aaron C Anselmo; Per H Nilsson; Apoorva Sarode; Vivek Gupta; Rudolf Urbanics; Janos Szebeni; Alan Christy Hunter; Samir Mitragotri; Tom Eirik Mollnes; Seyed Moein Moghimi
Journal:  Nat Nanotechnol       Date:  2017-04-10       Impact factor: 39.213

4.  Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.

Authors:  Fadi Fakhouri; Elena Goicoechea de Jorge; Frédérique Brune; Philippe Azam; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

5.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 6.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

Review 7.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

8.  Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.

Authors:  Xiaoxu Wang; Menno Van Lookeren Campagne; Kenneth J Katschke; Damodar Gullipalli; Takashi Miwa; Yoshiyasu Ueda; Yuan Wang; Matthew Palmer; Guolan Xing; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-12       Impact factor: 10.121

9.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.